DoP Invites Fresh Applications Under PLI Scheme for Bulk Drugs

DoP Invites Fresh Applications Under PLI Scheme for Bulk DrugsThe Department of Pharmaceuticals (DoP) has sought new applications under the Production Linked Incentive (PLI) scheme for bulk drugs, for products that have not been applied for or...

Prism Plates: Redefining Ready-To-Use Culture Media Plates Manufacturing

The pharmaceutical industry encounters pressing difficulties pertaining to products getting expired quickly while production and quality control costs remain elevated. Furthermore, transporting medications requires advanced logistics systems for refr

Chile Invites India to Support Its Public Healthcare with Medicines

The Embassy of India in Santiago, Chile sent a formal communication request to the Pharmaceuticals Export Promotion Council of India.

LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports

LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup ExportsThe Laghu Udyog Bharati which supports small-scale industries, have requested the government to lift the requirement that the cough syrups be analyzed at government-approved...

Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy

Hoth Therapeutics Unveils Promising Data for KIT-Targeting TherapyHoth Therapeutics Inc, a clinical stage biopharmaceutical company, also dedicated to novel medical needs, has reported very promising data of preclinical efficacy...

Physiment Pharmaceutical: Redefining Pharmaceuticals Through Innovation and Affordability

The pharmaceutical industry demonstrates strong market expansion due to healthcare needs' growth and rising chronic disease prevalence, as well as improved medical research capabilities.

Cipla Says Indian Generics Safe from US Pricing Rule

Cipla Says Indian Generics Safe from US Pricing RuleCipla Global CEO and Managing Director Umang Vohra stated that the recent US government directive ordering pharma firms to reduce the price of prescription medicine in 30 days is not likely to...

Piramal Pharma to Invest USD 90 Million in Expanding US Facilities

Piramal Pharma to Invest USD 90 Million in Expanding US FacilitiesMumbai-based Piramal Pharma Limited has made a USD 90 million investment to build out two of its facilities in the US. The announcement comes on the backdrop of the 2025 Select USA...

Emcutix in Collaboration with Canada-based Mantra Pharma Launch UREADERM

Emcutix Biopharmaceuticals Ltd., in collaboration with Canada-based Mantra Pharma Inc. – both subsidiaries of Emcure Pharmaceuticals Ltd. – has announced the pan-India launch of Ureaderm 10 percent & 20 percent, a urea-based moisturizer in cream

India Eyes Kuwait Pharma Market Amid Growing Import Demand

India Eyes Kuwait Pharma Market Amid Growing Import DemandIn a bid to tap into increasing pharmaceutical demand in Kuwait, the Indian Pharmaceuticals Export Promotion Council of India (Pharmexcil) is seeking comments from Indian pharma...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.